Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bolni Nagalo

Concepts (204)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
31
4.000
 Why?
Hepatitis B
8
2023
22
2.160
 Why?
Oncolytic Virotherapy
3
2022
16
1.720
 Why?
HIV Infections
11
2021
357
1.610
 Why?
Hepatitis B Surface Antigens
4
2018
9
1.550
 Why?
Syphilis
7
2019
27
1.340
 Why?
Carcinoma, Hepatocellular
4
2023
191
1.180
 Why?
Hepatitis C
5
2021
77
1.160
 Why?
Blood Transfusion
3
2021
121
1.160
 Why?
Liver Neoplasms
4
2023
326
1.080
 Why?
Seroepidemiologic Studies
10
2021
43
0.930
 Why?
Burkina Faso
16
2023
16
0.910
 Why?
Vesicular Stomatitis
1
2022
1
0.840
 Why?
Enzyme-Linked Immunosorbent Assay
4
2018
244
0.770
 Why?
Biliary Tract Neoplasms
4
2022
8
0.750
 Why?
HIV Antibodies
1
2018
10
0.660
 Why?
Blood-Borne Pathogens
1
2018
7
0.650
 Why?
HIV-1
4
2018
55
0.600
 Why?
Gabon
4
2019
4
0.530
 Why?
Mass Screening
1
2018
353
0.510
 Why?
Rural Population
1
2018
540
0.460
 Why?
Young Adult
11
2021
3958
0.460
 Why?
Skin Neoplasms
3
2024
488
0.440
 Why?
HIV Seroprevalence
2
2014
4
0.430
 Why?
Vesiculovirus
2
2022
5
0.430
 Why?
Humans
35
2024
49974
0.420
 Why?
Cholangiocarcinoma
2
2022
26
0.400
 Why?
Bile Duct Neoplasms
2
2022
29
0.400
 Why?
Adolescent
10
2021
6356
0.390
 Why?
Antibodies, Viral
1
2011
88
0.390
 Why?
Adult
16
2021
13236
0.380
 Why?
Plasma
1
2011
43
0.380
 Why?
Communicable Diseases
1
2011
55
0.370
 Why?
Melanoma
2
2024
285
0.330
 Why?
Prevalence
6
2018
944
0.290
 Why?
Female
17
2021
26472
0.280
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
989
0.280
 Why?
Middle Aged
12
2020
12069
0.280
 Why?
Male
14
2021
25241
0.270
 Why?
Sensitivity and Specificity
2
2018
861
0.270
 Why?
Hepacivirus
2
2018
104
0.260
 Why?
Cell Proliferation
4
2024
1007
0.240
 Why?
Molecular Docking Simulation
2
2023
73
0.240
 Why?
Monophenol Monooxygenase
1
2023
5
0.230
 Why?
Cell Line, Tumor
3
2024
1403
0.230
 Why?
Antineoplastic Agents
2
2024
1171
0.230
 Why?
Incidence
2
2021
1003
0.230
 Why?
Carcinoma, Pancreatic Ductal
1
2024
31
0.230
 Why?
Anti-HIV Agents
2
2014
42
0.230
 Why?
Drug Synergism
2
2021
150
0.220
 Why?
Hepatitis B virus
2
2023
27
0.220
 Why?
Psoriasis
1
2023
30
0.210
 Why?
Vesicular stomatitis Indiana virus
1
2022
2
0.210
 Why?
Dermatitis
1
2023
36
0.210
 Why?
Animals
6
2023
13187
0.210
 Why?
Antioxidants
2
2023
249
0.200
 Why?
Students, Medical
1
2023
157
0.190
 Why?
Treponema pallidum
2
2018
10
0.190
 Why?
Pancreatic Neoplasms
1
2024
208
0.190
 Why?
Flavonols
1
2020
4
0.190
 Why?
Risk Factors
4
2020
3613
0.190
 Why?
Viral Proteins
1
2022
155
0.190
 Why?
Disease Models, Animal
2
2023
1455
0.180
 Why?
Cymbopogon
1
2020
1
0.180
 Why?
Oils, Volatile
1
2020
12
0.180
 Why?
Immunotherapy
2
2021
238
0.180
 Why?
Receptors, KIR
1
2019
13
0.180
 Why?
Sequence Deletion
1
2020
66
0.180
 Why?
Protein Kinase Inhibitors
1
2021
204
0.170
 Why?
Mice
4
2023
5739
0.170
 Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.170
 Why?
Retrospective Studies
6
2022
6108
0.170
 Why?
Glutathione Transferase
1
2020
174
0.170
 Why?
Polymorphism, Genetic
1
2020
181
0.170
 Why?
Virology
1
2018
6
0.160
 Why?
HIV
1
2018
24
0.160
 Why?
Anti-Inflammatory Agents
1
2020
161
0.160
 Why?
Aged
6
2022
9310
0.160
 Why?
Molecular Structure
3
2024
297
0.150
 Why?
Immunotherapy, Adoptive
1
2018
156
0.140
 Why?
Blood Pressure
1
2019
512
0.140
 Why?
Polymorphism, Single Nucleotide
1
2019
485
0.140
 Why?
Odds Ratio
1
2018
545
0.140
 Why?
T-Lymphocytes
1
2018
338
0.130
 Why?
Polymerase Chain Reaction
2
2014
453
0.130
 Why?
Cross-Sectional Studies
2
2018
1557
0.130
 Why?
Cisplatin
3
2022
278
0.130
 Why?
HIV-2
1
2014
1
0.130
 Why?
Hospitals, Military
1
2014
7
0.130
 Why?
Time Factors
2
2018
2903
0.120
 Why?
Drug Monitoring
1
2014
77
0.120
 Why?
Syphilis Serodiagnosis
1
2014
4
0.120
 Why?
Antibodies, Monoclonal
1
2018
459
0.120
 Why?
RNA, Viral
2
2014
125
0.120
 Why?
Peritonitis
1
2014
27
0.120
 Why?
Community-Acquired Infections
1
2014
39
0.120
 Why?
Immunocompromised Host
1
2014
119
0.120
 Why?
Genotype
3
2023
537
0.120
 Why?
Viremia
1
2014
22
0.120
 Why?
Genetic Predisposition to Disease
3
2023
510
0.110
 Why?
Neoplasms
1
2023
1235
0.110
 Why?
Meningitis, Bacterial
1
2013
6
0.110
 Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.110
 Why?
Rubella
1
2012
4
0.110
 Why?
Antiretroviral Therapy, Highly Active
1
2012
34
0.110
 Why?
Toxoplasmosis
1
2012
15
0.110
 Why?
Antibodies, Protozoan
1
2012
12
0.110
 Why?
Gene Frequency
2
2023
94
0.110
 Why?
Bacteria
1
2014
224
0.100
 Why?
Case-Control Studies
3
2020
1131
0.100
 Why?
Bile Ducts, Intrahepatic
2
2022
15
0.100
 Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
 Why?
Pilot Projects
2
2013
699
0.100
 Why?
Drug Screening Assays, Antitumor
2
2024
136
0.100
 Why?
Apoptosis
3
2024
1101
0.100
 Why?
TOR Serine-Threonine Kinases
2
2023
77
0.100
 Why?
Pregnancy Complications, Infectious
1
2012
73
0.100
 Why?
Structure-Activity Relationship
2
2024
395
0.100
 Why?
Deoxycytidine
2
2021
27
0.100
 Why?
Hospitals, Teaching
1
2011
53
0.090
 Why?
Tumor Microenvironment
2
2024
212
0.090
 Why?
Autophagy
2
2023
169
0.090
 Why?
Xenograft Model Antitumor Assays
2
2021
211
0.090
 Why?
Programmed Cell Death 1 Receptor
2
2021
38
0.090
 Why?
Tumor Cells, Cultured
2
2020
465
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
595
0.090
 Why?
Prospective Studies
2
2012
2364
0.080
 Why?
Anti-Bacterial Agents
1
2014
744
0.080
 Why?
rho-Associated Kinases
1
2024
20
0.060
 Why?
Hedgehog Proteins
1
2024
33
0.060
 Why?
Blood Banks
2
2014
18
0.060
 Why?
Azoles
1
2023
28
0.060
 Why?
Immunomodulation
1
2024
37
0.060
 Why?
HLA-DRB1 Chains
1
2023
4
0.060
 Why?
Research
1
2023
110
0.050
 Why?
HLA Antigens
1
2023
52
0.050
 Why?
Interleukin-17
1
2023
36
0.050
 Why?
Pyrazoles
1
2023
113
0.050
 Why?
Medical Oncology
1
2023
94
0.050
 Why?
Computer Simulation
1
2023
280
0.050
 Why?
Platinum
1
2022
11
0.050
 Why?
Sirolimus
1
2023
62
0.050
 Why?
Alleles
1
2023
250
0.050
 Why?
Clone Cells
1
2022
74
0.050
 Why?
Proto-Oncogene Proteins c-akt
1
2023
157
0.050
 Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
 Why?
Phosphatidylinositol 3-Kinases
1
2023
141
0.050
 Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
 Why?
Program Evaluation
1
2023
354
0.050
 Why?
Pregnancy
3
2014
2607
0.050
 Why?
Enzyme Inhibitors
1
2023
391
0.050
 Why?
Cyclin-Dependent Kinase 2
1
2020
16
0.050
 Why?
Proto-Oncogene Proteins c-kit
1
2020
36
0.050
 Why?
Liver Cirrhosis
1
2023
218
0.050
 Why?
Cytidine Monophosphate
1
2020
1
0.050
 Why?
Curriculum
1
2023
401
0.050
 Why?
Flame Ionization
1
2020
3
0.050
 Why?
Medicine, Traditional
1
2020
18
0.040
 Why?
Mice, Inbred NOD
1
2020
96
0.040
 Why?
Plant Leaves
1
2020
43
0.040
 Why?
Gas Chromatography-Mass Spectrometry
1
2020
67
0.040
 Why?
Mice, SCID
1
2020
175
0.040
 Why?
Aldehydes
1
2020
83
0.040
 Why?
Cytokines
1
2023
612
0.040
 Why?
Genomics
1
2021
286
0.040
 Why?
Lipids
1
2020
147
0.040
 Why?
DNA, Viral
1
2019
133
0.040
 Why?
Sesquiterpenes
1
2020
90
0.040
 Why?
Cell Survival
1
2020
600
0.040
 Why?
Cohort Studies
1
2023
1422
0.040
 Why?
Immunohistochemistry
1
2021
973
0.040
 Why?
Genetic Association Studies
1
2019
117
0.040
 Why?
Inflammation
1
2023
604
0.040
 Why?
CTLA-4 Antigen
1
2018
25
0.040
 Why?
Alcohol Drinking
1
2020
224
0.040
 Why?
Neoplasm Recurrence, Local
1
2021
614
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1376
0.040
 Why?
Signal Transduction
1
2024
1618
0.040
 Why?
Body Mass Index
1
2020
652
0.040
 Why?
Phenotype
1
2019
729
0.030
 Why?
Smoking
1
2020
511
0.030
 Why?
CD4 Lymphocyte Count
1
2014
32
0.030
 Why?
Aged, 80 and over
1
2022
3129
0.030
 Why?
Opportunistic Infections
1
2014
58
0.030
 Why?
Risk Assessment
1
2019
1259
0.030
 Why?
Reagent Kits, Diagnostic
1
2014
18
0.030
 Why?
Genotyping Techniques
1
2014
20
0.030
 Why?
Hepatitis C Antibodies
1
2014
20
0.030
 Why?
Donor Selection
1
2014
12
0.030
 Why?
Drug Resistance, Bacterial
1
2014
71
0.030
 Why?
Drug Therapy, Combination
1
2014
377
0.030
 Why?
Weight Gain
1
2014
240
0.030
 Why?
Microbial Sensitivity Tests
1
2014
269
0.030
 Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
 Why?
Antibodies, Anti-Idiotypic
1
2012
19
0.030
 Why?
Molecular Diagnostic Techniques
1
2013
32
0.030
 Why?
Water
1
2012
77
0.030
 Why?
Disease Progression
1
2014
825
0.020
 Why?
Comorbidity
1
2014
615
0.020
 Why?
Socioeconomic Factors
1
2012
581
0.020
 Why?
Follow-Up Studies
1
2014
2182
0.020
 Why?
Treatment Outcome
1
2014
5141
0.010
 Why?
Child
1
2012
6847
0.010
 Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (204) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department